Use of Dapsone Gel, 5% for Treating Dermatitis Herpetiformis
NCT01115244
·
clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
1
Enrollment
OTHER
Sponsor class
Stopped
poor enrollment and lack of funding
Conditions
Dermatitis Herpetiformis
Interventions
DRUG:
Dapsone gel, 5%
Sponsor
Vanderbilt University Medical Center